Autologous SUPLEXA is under clinical development by Alloplex Biotherapeutics and currently in Phase I for Bladder Cancer.

Most common cancer which can occur in patients with untreated bladder stone is squamous cell carcinoma. This pathol ...

Following a recent trial, doctors at The Christie Hospital are optimistic about the study of HMBD-001 in the treatment of ...

The surge in cases of cancer in the under-50s has made many of us worry, with bowel, breast and lung cancers among those ...

Sacituzumab tirumotecan is under clinical development by Merck and currently in Phase III for Cervical Cancer.

The following is a summary of “Low-cost and label-free blue light cystoscopy through digital staining of white light ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Read the full article PDF by clicking here or on the link ...

Alcohol is the third leading preventable cause of cancer in the United States, Vivek Murthy said. Only Congress has the power to mandate changes to warning labels.

As an oncology consultant, I see many cases where patients are otherwise perfectly healthy and have followed a healthy ...

An East Lancashire man has been part of a clinical trial for a new experimental drug for the most common form of bladder cancer. The drug, which is a targeted chemotherapy, is specially designed to ...

But can it lead to bladder cancer? Also read | Natural ways to balance urinary pH and prevent infections: Urologist shares tips "Irregular contour of the bladder stone causes significant ...